PCNX4

gene
On this page

Summary

PCNX4 (pecanex 4, HGNC:20349) is a protein-coding gene on chromosome 14q23.1, encoding Pecanex-like protein 4 (Q63HM2).

Predicted to be located in membrane.

Source: NCBI Gene 64430 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 37 total
  • MANE Select transcript: NM_001330177

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20349
Approved symbolPCNX4
Namepecanex 4
Location14q23.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000126773
Ensembl biotypeprotein_coding
Entrez64430

Gene structure

Transcript identifiers

Ensembl transcripts: 16 — 8 protein_coding, 3 retained_intron, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined

ENST00000317623, ENST00000391611, ENST00000406854, ENST00000406949, ENST00000483571, ENST00000553513, ENST00000553898, ENST00000554534, ENST00000555569, ENST00000555740, ENST00000555929, ENST00000556360, ENST00000556907, ENST00000868337, ENST00000868338, ENST00000913742

RefSeq mRNA: 2 — MANE Select: NM_001330177 NM_001330177, NM_022495

CCDS: CCDS32091, CCDS81809

Canonical transcript exons

ENST00000406854 — 11 exons

ExonStartEnd
ENSE000015093916010758660108327
ENSE000016526126011832960118692
ENSE000017312446011497460115461
ENSE000034780176011470060114879
ENSE000035340326012119660121299
ENSE000035830426011594160116060
ENSE000036070836012563760125823
ENSE000036647726013397060148221
ENSE000036906356012421860125251
ENSE000036927276011571960115819
ENSE000038423136009192360092419

Expression profiles

Bgee: expression breadth ubiquitous, 278 present calls, max score 98.77.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 31.2789 / max 185.0766, expressed in 1813 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
13985521.51311801
1398575.45841677
1398602.13201148
1398581.0588753
1398560.5607322
1398590.3878186
1398610.168045

Top tissues by expression

294 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ventricular zoneUBERON:000305398.77gold quality
ganglionic eminenceUBERON:000402397.58gold quality
cortical plateUBERON:000534396.97gold quality
adrenal tissueUBERON:001830396.17gold quality
stromal cell of endometriumCL:000225596.09gold quality
right uterine tubeUBERON:000130295.85gold quality
tendon of biceps brachiiUBERON:000818895.35gold quality
adenohypophysisUBERON:000219694.48gold quality
left ovaryUBERON:000211994.45gold quality
right ovaryUBERON:000211894.42gold quality
pituitary glandUBERON:000000793.83gold quality
ovaryUBERON:000099293.71gold quality
bronchial epithelial cellCL:000232893.64gold quality
secondary oocyteCL:000065593.16gold quality
mucosa of paranasal sinusUBERON:000503093.13gold quality
oocyteCL:000002393.09gold quality
tendonUBERON:000004392.38gold quality
choroid plexus epitheliumUBERON:000391192.25gold quality
right adrenal gland cortexUBERON:003582792.10gold quality
right adrenal glandUBERON:000123391.71gold quality
body of uterusUBERON:000985391.71gold quality
colonic epitheliumUBERON:000039791.70gold quality
left adrenal glandUBERON:000123491.66gold quality
calcaneal tendonUBERON:000370191.63gold quality
endocervixUBERON:000045891.60gold quality
metanephros cortexUBERON:001053391.56gold quality
left adrenal gland cortexUBERON:003582591.41gold quality
tibiaUBERON:000097991.38gold quality
germinal epithelium of ovaryUBERON:000130491.35gold quality
endometriumUBERON:000129591.34gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-CURD-119yes35.12
E-GEOD-137537no642.93
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

45 targeting PCNX4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4533100.0069.482758
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-3617-3P99.9867.86918
HSA-MIR-60799.9773.625593
HSA-MIR-570-3P99.9672.414910
HSA-MIR-365899.9673.874379
HSA-MIR-651-3P99.9473.485177
HSA-MIR-141-3P99.9472.792421
HSA-MIR-200A-3P99.9472.682420
HSA-MIR-4760-3P99.9370.502385
HSA-MIR-449599.8272.083080
HSA-MIR-6842-5P99.8067.541587
HSA-MIR-7110-5P99.8067.841712
HSA-MIR-323A-3P99.7970.301739
HSA-MIR-200A-5P99.7669.10949
HSA-MIR-200B-5P99.7669.05948
HSA-MIR-808499.7369.571760
HSA-MIR-128399.6972.423009
HSA-MIR-46699.6770.852863
HSA-MIR-561-3P99.6470.903647
HSA-MIR-651-5P99.6468.491104
HSA-MIR-6752-5P99.5967.321243
HSA-MIR-3942-3P99.5769.032854
HSA-MIR-6751-5P99.5664.991145
HSA-MIR-54399.5269.032595
HSA-MIR-582-5P99.4770.792635
HSA-MIR-6507-3P99.3567.321059

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriopcnx4ENSDARG00000060785
mus_musculusPcnx4ENSMUSG00000034501
rattus_norvegicusAABR07064804.1ENSRNOG00000005568

Paralogs (3): PCNX1 (ENSG00000100731), PCNX2 (ENSG00000135749), PCNX3 (ENSG00000197136)

Protein

Protein identifiers

Pecanex-like protein 4Q63HM2 (reviewed: Q63HM2)

Alternative names: Hepatitis C virus F protein-binding protein 2, Pecanex homolog protein 4

All UniProt accessions (8): Q63HM2, B5MC47, B6ZDM2, H0YIY3, H0YJ84, H0YJN3, H0YJV9, H9KV87

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the pecanex family.

RefSeq proteins (2): NP_001317106, NP_071940 (=MANE)

Domains & families (InterPro)

IDNameType
IPR007735Pecanex_CDomain
IPR039797PecanexFamily

Pfam: PF05041

UniProt features (23 total): transmembrane region 15, sequence variant 3, glycosylation site 2, sequence conflict 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q63HM2-F178.420.40

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 1120, 1147

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 79 (showing top): RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, BEIER_GLIOMA_STEM_CELL_DN, chr14q23, POU3F2_02, WGGAATGY_TEF1_Q6, KIM_WT1_TARGETS_DN, JOHNSTONE_PARVB_TARGETS_3_DN, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, DELACROIX_RARG_BOUND_MEF, ARNT2_TARGET_GENES, ATF5_TARGET_GENES, FEV_TARGET_GENES, GLI3_TARGET_GENES, GUCY1B1_TARGET_GENES, HES4_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

372 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PCNX4CEP44Q9C0F1445
PCNX4MIDEASQ6PJG2397
PCNX4RPRD2Q5VT52395
PCNX4DHRS7Q9Y394374
PCNX4SLC35A4Q96G79374
PCNX4TBC1D9Q6ZT07368
PCNX4UNC79Q9P2D8366
PCNX4RPS12P25398339
PCNX4RALGAPA1Q6GYQ0337
PCNX4FAXDC2Q96IV6336
PCNX4CCDC141Q6ZP82325
PCNX4MDGA2Q7Z553323
PCNX4PILRBQ9UKJ0320
PCNX4CCNIQ14094317
PCNX4BCAS2O75934305

IntAct

11 interactions, top by confidence:

ABTypeScore
PCNX4psi-mi:“MI:0915”(physical association)0.510
PCNX4psi-mi:“MI:0915”(physical association)0.510
FBP1PCNX4psi-mi:“MI:0915”(physical association)0.370
PCNX4DISC1psi-mi:“MI:0915”(physical association)0.000
PCNX4CEP63psi-mi:“MI:0915”(physical association)0.000
PCNX4MTNR1Bpsi-mi:“MI:0915”(physical association)0.000
DISC1PCNX4psi-mi:“MI:0915”(physical association)0.000
CEP63PCNX4psi-mi:“MI:0915”(physical association)0.000
PCNX4wecEpsi-mi:“MI:0915”(physical association)0.000

BioGRID (10): PCNXL4 (Two-hybrid), PCNXL4 (Two-hybrid), PCNXL4 (Affinity Capture-RNA), PCNXL4 (Affinity Capture-RNA), PCNXL4 (Affinity Capture-MS), PCNXL4 (Affinity Capture-RNA), PCNXL4 (Affinity Capture-MS), PCNXL4 (Affinity Capture-RNA), PCNXL4 (Two-hybrid), PCNXL4 (Two-hybrid)

ESM2 similar proteins: A0A291NUG3, A0A291NUI4, A0A291NUI5, A2AN08, A2CBW9, A2RUW7, A8E5V9, A9CB91, B8XX90, E1C7U0, E7F4N7, F1M391, O36397, P03207, P03246, P03247, P06501, P0C722, P0C723, P0CZ24, P11823, P11824, P18801, P37588, P49408, P52132, P68966, P68967, P77206, Q02189, Q10115, Q148F6, Q2HRD2, Q2KI99, Q3KPU7, Q3TBT3, Q3UVY5, Q5HZQ9, Q5K6N0, Q5XIF1

Diamond homologs: A2RUW7, A6NKB5, E9PSU6, P18490, Q3UVY5, Q5DU28, Q5HZQ9, Q63HM2, Q8VI59, Q96RV3, Q98UF7, Q9H6A9, Q9QYC1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

37 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance12
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2475 predictions. Top by Δscore:

VariantEffectΔscore
14:60115077:C:Gdonor_gain1.0000
14:60115089:T:Gdonor_gain1.0000
14:60115096:A:AGdonor_gain1.0000
14:60115163:G:GTdonor_gain1.0000
14:60115168:A:Tdonor_gain1.0000
14:60115936:T:Aacceptor_gain1.0000
14:60115939:A:ACacceptor_loss1.0000
14:60115940:GGT:Gacceptor_gain1.0000
14:60115940:GGTA:Gacceptor_gain1.0000
14:60115940:GGTAT:Gacceptor_gain1.0000
14:60116056:TACTG:Tdonor_gain1.0000
14:60116057:ACTG:Adonor_gain1.0000
14:60116058:CTG:Cdonor_gain1.0000
14:60116059:TG:Tdonor_gain1.0000
14:60116059:TGG:Tdonor_loss1.0000
14:60116060:GG:Gdonor_gain1.0000
14:60116061:G:GAdonor_loss1.0000
14:60116061:G:GGdonor_gain1.0000
14:60116062:T:Gdonor_loss1.0000
14:60116850:G:GGdonor_gain1.0000
14:60116888:A:Gdonor_gain1.0000
14:60118327:AGGTT:Aacceptor_gain1.0000
14:60118328:GGTTG:Gacceptor_gain1.0000
14:60121185:A:Gacceptor_gain1.0000
14:60121191:TGTA:Tacceptor_loss1.0000
14:60121193:TAGGT:Tacceptor_loss1.0000
14:60121194:AGGTC:Aacceptor_loss1.0000
14:60121195:G:Aacceptor_loss1.0000
14:60121295:TTAAG:Tdonor_loss1.0000
14:60121296:TAAG:Tdonor_loss1.0000

AlphaMissense

7652 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:60134111:A:CS1137R0.996
14:60134113:T:AS1137R0.996
14:60134113:T:GS1137R0.996
14:60107674:G:CK12N0.995
14:60107674:G:TK12N0.995
14:60121241:G:CR663P0.995
14:60121249:T:AW666R0.994
14:60121249:T:CW666R0.994
14:60125761:T:AW1069R0.994
14:60125761:T:CW1069R0.994
14:60134143:T:AN1147K0.992
14:60134143:T:GN1147K0.992
14:60134145:T:CL1148P0.992
14:60134054:T:AW1118R0.991
14:60134054:T:CW1118R0.991
14:60124218:G:AG683R0.990
14:60124218:G:CG683R0.990
14:60134057:G:CA1119P0.990
14:60124257:G:CA696P0.989
14:60133992:T:CL1097P0.989
14:60134064:T:CL1121P0.989
14:60134092:C:AN1130K0.989
14:60134092:C:GN1130K0.989
14:60124218:G:TG683W0.988
14:60124917:T:AW916R0.988
14:60124917:T:CW916R0.988
14:60134106:G:CR1135P0.988
14:60107694:G:CR19P0.987
14:60121229:G:CR659P0.987
14:60124377:T:GY736D0.987

dbSNP variants (sampled 300 via entrez): RS1000007676 (14:60129351 T>A,C), RS1000054383 (14:60145203 C>A,T), RS1000061515 (14:60110469 A>C), RS1000158104 (14:60104111 G>A,C,T), RS1000163854 (14:60144150 GAAT>G), RS1000227231 (14:60102829 A>T), RS1000262722 (14:60104768 C>G), RS1000353031 (14:60138818 G>A), RS1000354187 (14:60092850 C>G,T), RS1000376449 (14:60099064 G>GAGGAA), RS1000431412 (14:60138284 G>A,C), RS1000442058 (14:60098896 C>T), RS1000505381 (14:60145757 C>T), RS1000522860 (14:60121121 G>A,T), RS1000633170 (14:60105878 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST90000025_534Appendicular lean mass4.000000e-11

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004980appendicular lean mass

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
Tobacco Smoke Pollutionaffects expression, decreases expression3
Valproic Acidaffects expression, decreases expression2
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
bisphenol Adecreases expression1
trichostatin Aaffects expression1
tris(2-butoxyethyl) phosphateaffects expression1
beta-lapachonedecreases expression, increases expression1
K 7174increases expression1
Bortezomibincreases expression1
Air Pollutantsincreases abundance, decreases expression1
Air Pollutants, Occupationaldecreases expression1
Benzo(a)pyrenedecreases methylation1
Coaldecreases expression, increases abundance1
Copperaffects binding, increases expression1
Disulfiramaffects binding, increases expression1
Doxorubicindecreases expression1
Nickeldecreases expression1
Paraoxonincreases expression1
Quercetindecreases expression1
Smokeincreases abundance, decreases expression1
Vanadatesincreases expression1
Cyclosporinedecreases expression1
Copper Sulfateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.